REMINDER: Our user survey closes on Friday, please submit your responses here.
What the hell is going on here?? Massive sells going through way below the bid
I've been researching this share recently. I especially like the manner in which the company look after their staff. The only slight concern what portion of their revenues does the hello neighbor franchise make up? Does anyone know. Thanks in advance
Liberum 2023 estimate is:
£120m Revenue
£71m PBT
Assuming tax at 20% that leaves a PAT of c. £56m so a PE of 14.
Alpha normal smash it out of the park and come in ahead of forecasts, so current forward PE for 2023 is probably more like 12 or 13. This is great value especially considering the rate of growth here is phenomenal. Those buying at current prices are getting an absolute bargain imo.
If the patient is resistant to Dox, no ethical clinician is going to propose the AVA6000 trial. All the patients who enter this trial do so because they hope it will extend what little time they have left. "Hope" is central to the journey of any cancer patient. Its often hope that keeps them alive and gives them the strength to endure arduous treatments. For those patients who have bravely enrolled on the AVA6000 trial, it will be their hope, that the minimum result will be a few extra months. For some this hope (however small) may include the chance of extra years of life or even a complete cure. For patients, the efficacy of the trial will be determined through scans. Scans which show tumor regression or at least no more tumor growth give hope. Its unlikely we get any data on the results of these scans, but who knows, maybe AS will surprise us
You could have purchased Moderna Inc in August 2019 for $12. Two years later you could have sold for $497.
No one is saying for certain that Avacta will see a similar price appreciation in such a short period of time. However, it goes to show the kind of rise we COULD see if AVA6000 is successful. So far the signs are good and if the data is a good as we all think its going to be for phase 1a then I think even you will agree the share price is far too low at current levels.
The fact the Ct value was not included in the performance stats is a red flag for me. In my opinion if the results were based on CT values of greater than 27 they would have definitely mentioned it. This leads me to believe the performance is AT BEST based on Ct values of <27. Don't forget, at Ct values of <27 the Avacta test is 100%. With this in mind, If my thesis is correct, the NCYT LFT will struggle to get any meaningful sales
Today's RNS from NCYT on the performance of their lateral flow test missed out a key bit of information. What Ct value was it measured against? Without this bit of information we are completely in the dark about the efficacy of the test.
Nice write up on RENX
https://uksmallcapstocks.com/f/renalytixai-renx
I've been doing a lot of research on RENX over the weekend. The only thing that is confusing me a little is how have the company been able to agree a GWAC contract offered through the GSA without FDA approval? Not only this but getting the MCIT ruling passed would seem critical for this deal as the Veterans Administration advises its beneficiaries to also have medicare. In other words, getting medicare approval is critical for any meaningful sales under the GWAC contract. Also, does anyone know the current testing capacity. How many tests are the company currently able to perform per month?
Hi,
I'm new to RENX. After reading yesterdays RNS on the big US Government contract win I immediately starting researching this company. I'm a bit confused as to the state of play with the FDA and what exactly the MCIT ruling implies. Do the company already have clearance to sell the tests from the FDA? If not, when are we likely to hear from the FDA on this? I'm a bit confused as I read that the test had already been given clearance from the FDA's via their "Designated Breakthrough Devices" route. Also, what is the Medicare/MCIT ruling all about and how does it impact on RENX? Sorry for the newbie questions, and thanks in advance to anyone who can help me out with this.
Thanks for sharing. That write up has saved me a few hours of having to trawl through the Admission document. I'm quite tempted to buy some of these.
Nice write up on SMRT.
https://uksmallcapstocks.com/f/smartspace-software-smrt
I'm sure you have all heard stories of Bitcoin holders who cannot access their Bitcoin because they have lost their private key and/or forgotten the password to it. Because Bitcoin is decentralised it means only you are in control of your private key and password so there is no one to call if you forget it. Mode take this stress away by holding the Bitcoin for you. If you forget the password to your Mode app, you can always get in contact with them to reset it for you, this way there is no chance of you ever losing your Bitcoin. The Mode app is designed for Bitcoin newbies. It takes the complication out of buying Bitcoin for the first time and removes the stress/fear of losing your private key or forgetting your password.
I'm invested here but this comment is a little wide of the mark. "We offer the cheapest trading platform, so PI's that fancy themselves as BTC traders will love us". Yes, there will undoubtedly be some trading via the app, however any serious traders will use major crypto exchanges like Binance where the fee is only 0.14%
Despite being an experienced investor I have never owned a gold company until now. I took a position on Friday in Landore after digesting what I thought was an excellent RNS. Its only a small position to start with as I have minimal experience in analysing gold companies. I'm taking the time to research the sector with a view to hopefully adding to my LND position as a gain more understanding of the investment opportunity on offer. Since I'm not au fait with some of the terminology used in gold mining/exploring, I have written a quick summary in lay terms of the investments case as I see it. I would be grateful if those with a lot more knowledge than me (most of you on here) could scan over what I have written, correct me where appropriate and maybe add a bit more meat to the bone.
As far as I can make out, LND own a potentially multi-million oz gold resource in Ontario, Canada. To date they have discovered a confirmed 1m ounces of gold. Despite the low grade, the resource can be mined relatively cheaply since its open pit. Over the last few months the company have been further drilling the resource. The drilling has been split between 1) Infill drilling at the location of the original gold find, the aim of which is to increase the 1m oz to 1.3m oz. 2) drilling at a new location along the strike
The latest update showed that the recent drilling campaign has hit gold at the new location as well as hitting gold at a greater depth at the existing confirmed resource. We will find out in the next few months of the size of the upgrade once the new discoveries are defined. Over the coming weeks and months, we will be getting back the assay results from the lab which will be used to make this calculation. Its very encouraging that the most recent assay results all showed the presence of gold, some of which were at very good grades - apparently !
The gold deposit extends along a 31km strike which is 100% owned by LND. To date they have only drilled c. 1/4 of this. Due to the successful drilling campaigns and a similar geology along the strike, it stands reason that there could be further discoveries, suggesting the resource has multi million oz potential. I notice some on here are suggesting the total resource has the potential to be north of 5m oz's. In addition, the site has other deposits inc Nickel which could be explored.
The project is run by Bill Humphries (CEO). After Bill's success at Brancote Holdings (1999 – 2002), he is now applying the same successful business model to LND. Eric Sprott is a Canadian billionaire and gold expert, he has taken a 10% stake in LND.
The Broker, Cenkos has a NPV5 of £211m – I believe this only takes into account the 1m oz of confirmed gold deposits and assumes a gold price of $1,650/oz. Further defined resource will increase the NPV. Using a discount to NAVx 0.25, the broker has a current fair value at £59m/64p per share.
In a nut shell, that's the investment case as I see it. Comments wel
This won't re-rate until we are able to crunch the financial numbers in our calculators. Its impossible to value until that point.